Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation

Allogeneic haematopoietic stem cell transplantation currently represents the primary potentially curative treatment for cancers of the blood and bone marrow. While relapse occurs in approximately 30% of patients, few risk-modifying genetic variants have been identified. The present study evaluates t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ritari, J., Hyvärinen, K., Koskela, S., Itälä-Remes, M., Niittyvuopio, R., Nihtinen, A., Salmenniemi, U., Putkonen, M., Volin, L., Kwan, T., Pastinen, T., Partanen, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326954/
https://www.ncbi.nlm.nih.gov/pubmed/30089915
http://dx.doi.org/10.1038/s41375-018-0229-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326954/
https://www.ncbi.nlm.nih.gov/pubmed/30089915
http://dx.doi.org/10.1038/s41375-018-0229-3

Ejemplares similares